DetailsChartProfilRisikomatrixNachrichtenDokumente

Candriam Equities L Oncology Impact I/  LU1864482358  /

Fonds
NAV23.05.2024 Diff.-25,1201 Ertragstyp Ausrichtung Fondsgesellschaft
2.851,1899USD -0,87% thesaurierend Aktien weltweit Candriam ▶
 

Monatliche Performance

  Jan Feb Mrz Apr Mai Jun Jul Aug Sep Okt Nov Dez Gesamt
2018 - - - - - - - - - - - -6,00 -
2019 10,25 6,19 2,66 -3,64 -2,56 8,69 0,30 -0,28 -3,18 5,10 7,96 5,03 +41,52%
2020 -1,46 -5,35 -3,07 12,12 8,54 1,42 4,43 2,15 3,52 -2,21 5,82 3,86 +32,43%
2021 0,55 -4,20 -0,09 2,33 0,17 3,53 -0,96 5,58 -3,77 3,37 -6,37 3,99 +3,43%
2022 -10,49 -1,75 4,65 -5,85 -1,33 0,04 4,37 -3,14 -4,71 7,04 6,07 -3,44 -9,67%
2023 2,16 -3,88 1,38 2,83 -2,56 0,08 0,89 -2,02 -5,25 -6,36 9,21 5,73 +1,11%
2024 1,37 4,14 1,49 -3,38 3,80 - - - - - - - -

Kennzahlen

  lfd. Jahr 6 Monate 1 Jahr 3 Jahre 5 Jahre
Volatilität 10,73% 10,97% 11,74% 14,70% 17,24%
Sharpe Ratio 1,54 2,68 0,15 -0,18 0,38
Bester Monat +5,73% +9,21% +9,21% +9,21% +12,12%
Schlechtester Monat -3,38% -3,38% -6,36% -10,49% -10,49%
Maximaler Verlust -6,77% -6,77% -15,55% -25,08% -25,08%
Outperformance +19,13% - +25,64% - -
 
Alle Kurse in USD

Tranchen

Titel   Ertragstyp Rückn. Preis 1 Jahr 3 Jahre
Candriam Equities L Oncology Imp... thesaurierend 2.373,6201 +5,87% +4,61%
Candriam Equities L Oncology Imp... thesaurierend 2.536,3999 +6,01% +5,00%
Candriam Equities L Oncology Imp... thesaurierend 205,5000 +2,36% -6,17%
Candriam Equities L Oncology Imp... thesaurierend 2.219,1599 +3,13% +15,22%
Candriam Equities L Oncology Imp... ausschüttend 1.592,9000 +5,53% +3,61%
Candriam Equities L Oncology Imp... thesaurierend 243,5800 +4,08% +13,92%
Candriam Equities L Oncology Imp... ausschüttend 233,5500 +4,54% +0,75%
Candriam Equities L Oncology Imp... ausschüttend 189,1400 +5,44% +3,31%
Candriam Equities L Oncology Imp... ausschüttend 20.588,0000 +1,43% +1,24%
Candriam Equities L Oncology Imp... thesaurierend 157,0000 +3,01% +14,83%
Candriam Equities L Oncology Imp... thesaurierend 2.089,5901 +3,32% -3,48%
Candriam Equities L Oncology Imp... thesaurierend 258,1100 +4,96% +16,83%
Candriam Equities L Oncology Imp... thesaurierend 204,9800 +1,94% -7,27%
Candriam Equities L Oncology Imp... thesaurierend 283,6000 +5,42% +3,29%
Candriam Equities L Oncology Imp... thesaurierend 191,9200 +3,21% -
Candriam Equities L Oncology Imp... thesaurierend 1.830,5000 +3,46% -
Candriam Equities L Oncology Imp... thesaurierend 2.851,1899 +5,53% +3,61%
Candriam Equities L Oncology Imp... thesaurierend 156,5900 - -
Candriam Equities L Oncology Imp... thesaurierend 271,3500 +4,54% +0,73%

Performance

lfd. Jahr  
+7,45%
6 Monate  
+15,19%
1 Jahr  
+5,53%
3 Jahre  
+3,61%
5 Jahre  
+64,12%
10 Jahre     -
seit Beginn  
+90,08%
Jahr
2023  
+1,11%
2022
  -9,67%
2021  
+3,43%
2020  
+32,43%
2019  
+41,52%